Skip to content
Laurent Pharma
  • ABOUT US
    • Leadership
    • Board of directors
    • Key advisors
  • SCIENCE
    • LAU-7b
    • Membrane lipids
    • Resolution of inflammation
  • PIPELINE
    • Overview
    • Cystic fibrosis
    • COVID-19
  • NEWS & EVENTS
  • CONTACT
  • ABOUT US
    • Leadership
    • Board of directors
    • Key advisors
  • SCIENCE
    • LAU-7b
    • Membrane lipids
    • Resolution of inflammation
  • PIPELINE
    • Overview
    • Cystic fibrosis
    • COVID-19
  • NEWS & EVENTS
  • CONTACT

Blog

  • Post published:24 May 2023

Laurent Pharma to participate to BIO International Convention

Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA
Share

Latest News

  • Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID
  • Laurent Pharma to participate to BIO International Convention
  • LAU-7b featured in The Pharmaceutical Journal among next-generation antivirals targeting COVID-19

Science

  • LAU-7b
  • Membrane lipids
  • Resolution of inflammation

Pipeline

  • Overview
  • Cystic fibrosis
  • COVID-19

CONTACT

  • Address:1010 Sherbrooke St West, Suite 2401 Montréal (Québec) H3A 2R7 Canada
  • Email:info@laurentpharma.comOpens in your application
Laurent Pharmaceuticals Inc. © 2023 All Rights Reserved.